Infectious complications of rituximab therapy in renal disease

Rituximab, an anti-CD20 monoclonal antibody, was originally used to treat B-cell malignancies. Its use has significantly increased in recent years, as it is now also used to treat a variety of autoimmune diseases including rheumatoid arthritis and ANCA-associated vasculitis (AAV). Initial studies su...

Descripción completa

Detalles Bibliográficos
Autores principales: Nixon, Andrew, Ogden, Leanne, Woywodt, Alexander, Dhaygude, Ajay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Rituximab
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570071/
https://www.ncbi.nlm.nih.gov/pubmed/28852481
http://dx.doi.org/10.1093/ckj/sfx038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570071/
https://www.ncbi.nlm.nih.gov/pubmed/28852481
http://dx.doi.org/10.1093/ckj/sfx038

Ejemplares similares